Search for: klebsiella

• 56 Results (Page 1 of 3)
• • Relevance 

    • Relevance
    • Published
    • Price
    Sort by Relevance Published Price

Klebsiella Pneumoniae Infections - Pipeline Insight, 2020

•  Clinical Trials
• February 2020
• 106 pages

From

€1335EUR$1,500USD£1,140GBP

Klebsiella pneumoniae Infections - Pipeline Review, H2 2020

•  Drug Pipelines
• October 2020
• 140 pages

From

€1780EUR$2,000USD£1,520GBP

Klebsiella pneumoniae Infections (Infectious Disease) - Drugs In Development, 2021

•  Report
• July 2021
• 167 pages

From

€1780EUR$2,000USD£1,520GBP

Klebsiella Infections (Infectious Disease) - Drugs in Development, 2021

•  Report
• April 2021
• 30 pages

From

€1780EUR$2,000USD£1,520GBP

Klebsiella pneumoniae Infections R&D Pipeline Analysis Report, Q4 2020

•  Report
• October 2020
• 143 pages

From

€1566EUR$1,759USD£1,337GBP

€1957EUR$2,199USD£1,671GBP

Klebsiella Pneumoniae Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019

•  Drug Pipelines
• January 2019
• 60 pages

From

€1780EUR$2,000USD£1,520GBP

Klebsiella pneumoniae Infections Drug Pipeline Report 2020 - Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

•  Drug Pipelines
• October 2019
• 100 pages

From

€1210EUR$1,359USD£1,033GBP

€1512EUR$1,699USD£1,291GBP

2019 Klebsiella pneumoniae Infections R&D Pipeline Drugs, Companies, Trials and Developments

•  Report
• March 2019
• 100 pages

From

€1566EUR$1,759USD£1,337GBP

€1957EUR$2,199USD£1,671GBP

Klebsiella pneumoniae Infections R&D Pipeline Analysis Report, H2-2018

•  Report
• August 2018
• 90 pages

From

€1566EUR$1,760USD£1,338GBP

€1958EUR$2,200USD£1,672GBP

Klebsiella pneumoniae Drug Development Pipeline Study, H2 2018

•  Report
• August 2018
• 90 pages

From

€854EUR$960USD£730GBP

€1068EUR$1,200USD£912GBP

Bovine Respiratory Disease Treatment Market - Growth, Trends, and Forecast (2020 - 2025)

•  Report
• April 2020
• 111 pages

From

€3404EUR$3,825USD£2,907GBP

€3783EUR$4,250USD£3,230GBP

Cell Wall Synthesis Inhibitors - Pipeline Insight, 2021

•  Drug Pipelines
• September 2021
• 120 pages

From

€2225EUR$2,500USD£1,900GBP

Uncomplicated Urinary Tract Infection - Epidemiology Forecast to 2030

•  Drug Pipelines
• July 2021
• 70 pages

From

€3338EUR$3,750USD£2,850GBP

Intra Abdominal Infection Market: By Causing Agents, By Diagnosis, Ultrasound, By Drugs, By Geography - Forecast 2016-2021

•  Report
• February 2016
• 134 pages

From

€4673EUR$5,250USD£3,990GBP

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products: 2021-2026

•  Report
• June 2021
• 213 pages

From

€4895EUR$5,500USD£4,180GBP

Asia-Pacific Aerospace Antimicrobial Coatings Market 2020-2026

•  Report
• December 2020

From

€1762EUR$1,980USD£1,505GBP

€1958EUR$2,200USD£1,672GBP

Bacteriology Rapid Tests and POC - Medical Devices Pipeline Assessment, 2020

•  Report
• November 2020
• 555 pages

From

€3560EUR$4,000USD£3,040GBP

Beta - Lactamase Inhibitor - Pipeline Insight, 2021

•  Clinical Trials
• June 2021

From

€1335EUR$1,500USD£1,140GBP

Molbio Diagnostics Pvt Ltd - Product Pipeline Analysis, 2019 Update

•  Company Profile
• August 2019
• 69 pages

From

€668EUR$750USD£570GBP

Antibiotics: The Quest for New Super Drugs: Technologies, Markets, Competitors and Opportunities: 2017-2022 Analysis and Forecasts

•  Report
• July 2017
• 299 Pages

From

€2136EUR$2,400USD£1,824GBP

• 56 Results (Page 1 of 3)
• • 1
  • 2
  • 3
  • 